Idera Pharmaceuticals, Inc. Announces Resignation of Jonathan Yingling as Senior Vice President and Chief Scientific Officer, Effective on January 31, 2020

On January 22, 2020, Dr. Jonathan Yingling notified Idera Pharmaceuticals, Inc. of his resignation as the company’s Senior Vice President and Chief Scientific Officer, with such resignation effective January 31, 2020.